Price target
1,216.640.000.00%
The 1 analyst offering 1 year price forecasts for ORMP have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings to ORMP in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
ORMP EPS for the last quarter is 0.83 ILA despite the estimation of 0.04 ILA. In the next quarter EPS is expected to reach 0.02 ILA. Track more of ORAMED PHARM financials and stay on top of what is up with the company.
In the next quarter ORAMED PHARM revenue is expected to reach 0.00 ILA. Check out ORAMED PHARM revenue and earnings and make informed decisions.
According to analysts, ORMP price target is 1,216.64 ILA with a max estimate of 1,216.64 ILA and a min estimate of 1,216.64 ILA. Check if this forecast comes true in a year, meanwhile watch ORAMED PHARM stock price chart and keep track of the current situation with ORMP news and stock market news.